Wall Street also was waiting to see whether President Donald Trump would follow through on his pledge to enact tariffs on ...

Amgen’s Blincyto (blinatumomab) has been approved by the European Commission (EC) to treat certain acute lymphoblastic ...

Prices have likely climbed on a swift move from investors to safety due to Trump tariff threats, rising geopolitical tensions and U.S. government debt, and fear of a potential tech rout that could ...

Startup founders are inherently problem solvers. Whether it’s identifying a pain point inside an esoteric industry or building a better mousetrap, almost every journey centers on finding a way to make ...

Sarclisa is the first anti-CD38 treatment approved in China for patients with newly diagnosed multiple myeloma ineligible for transplant Approval based on positive results from the IMROZ phase 3 study ...

The ASX 200 benchmark touched an all-time record of 8566 points before pulling back slightly. At around lunch time Friday, ...

Readers had a lot to say about my latest column on the Food and Drug Administration’s proposed front-of-package labels. Most ...

Leerink Partners analyst Puneet Souda has maintained their bullish stance on DHR stock, giving a Buy rating yesterday.Invest with Confidence: ...

A meeting was held at the Ministry of Health, on 28th January 2025, presided by Minister of Health, Dr. Nalinda Jayatissa at ...

Officials previously argued that all 32 severance agreements were exempt as confidential personnel records under Virginia's ...

This year started off on a positive note with the good news that renewable energy will now account for the majority of new ...